Extendicare Inc. (TSE:EXE – Get Rating) – Investment analysts at National Bank Financial dropped their FY2024 earnings per share estimates for Extendicare in a research report issued to clients and investors on Monday, March 6th. National Bank Financial analyst T. Woolley now forecasts that the company will earn $0.34 per share for the year, down from their prior forecast of $0.45. The consensus estimate for Extendicare’s current full-year earnings is $0.23 per share.
EXE has been the subject of a number of other research reports. Royal Bank of Canada lowered their price objective on Extendicare from C$7.50 to C$7.00 and set a “sector perform” rating for the company in a research report on Monday. National Bankshares lowered their price objective on Extendicare from C$7.50 to C$7.00 and set a “sector perform” rating on the stock in a report on Monday, January 30th.
Extendicare Stock Down 0.8 %
Extendicare Announces Dividend
The business also recently announced a monthly dividend, which will be paid on Wednesday, March 15th. Stockholders of record on Tuesday, February 28th will be issued a $0.04 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 7.48%. The ex-dividend date of this dividend is Monday, February 27th. Extendicare’s payout ratio is currently -960.00%.
Extendicare Company Profile
Extendicare Inc, through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; retirement living services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as contract and consulting services to third parties.
Featured Articles
- Fossil Group: Should You Bet On Consumer Discretionary In 2023?
- BJ’s Wholesale Club Stock Moves Higher After Strong Results
- Monthly Realty Income is About to Get Bigger
- 3 Large Cap Dividend Challengers for Millennial Investors
- Sea Ltd Is On The Verge Of A 100% Rally, Should You Buy?
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.